Dr. Kulkarni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
# L154
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2018 - 2021
Northwestern University The Feinberg School of MedicineClass of 2017
Certifications & Licensure
CA State Medical License 2019 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Statin use is associated with protection against acute cholangitis in patients with primary sclerosing cholangitis: a multi-center retrospective cohort study.Chiraag Kulkarni, George Cholankeril, Touran Fardeen, Joseph Rathkey, Samir Khan
Clinical and Translational Gastroenterology. 2025-01-21 - Artificial intelligence and machine learning technologies in ulcerative colitis.Chiraag Kulkarni, Derek Liu, Touran Fardeen, Eliza Rose Dickson, Hyunsu Jang
Therapeutic Advances in Gastroenterology. 2024-01-01 - Severe Diarrhea and Weight Loss Due to Protein-Losing Enteropathy: Don't Pass Up the PAS Stain.Aaron Yeoh, Chiraag Kulkarni, Emily Ryan, Gerald Berry, George Triadafilopoulos
Digestive Diseases and Sciences. 2023-08-01
Press Mentions
In IBD Patients, Statin Use Associated with Lower Risk of Developing PSCJune 4th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
